New

Capstan Therapeutics

The AI engine Fit Assessment

Beta

Capstan Therapeutics develops RNA-based therapies using targeted delivery systems to enhance treatments for oncology, fibrosis, and inflammation-related diseases.

Blurb

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

HQ Location

San Diego (United States)

Founded

2021

Employees

51 - 200

Total funding raised

$2.44B

Funding Status

Acquired by AbbVie, June 2025

Capstan Therapeutics is now part of AbbVie.



AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.



For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.